Augmenting T Helper Cell Immunity in Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
365-371
Author(s):
K. L. Knutson and M. L. Disis
CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
109-118
Author(s):
E. Lazzeri and P. Romagnani
Chemosensitization by Antisense Oligonucleotides Targeting MDM2
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
51-56
Author(s):
Roberto Bianco, Fortunato Ciardiello and Giampaolo Tortora
DNAM-1 (CD226): A Two-Sword Fencer for Innate and Adaptive Immunity
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
4
Page:
53-58
Author(s):
Akira Shibuya, Satoko Tahara-Hanaoka and Kazuko Shibuya
Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Journal:
Current Pediatric Reviews
Volume:
1
Page:
55-61
Author(s):
Yoshiaki Tsuchida and Toshiji Shitara
Herpesvirus / Retrovirus Chimeric Vectors
Journal:
Current Gene Therapy
Volume:
4
Page:
409-416
Author(s):
Alberto L. Epstein and Roberto Manservigi
Alternative Gene Therapy Strategies for the Repair of Craniofacial Bone Defects
Journal:
Current Gene Therapy
Volume:
4
Page:
469-485
Author(s):
Juan Dai, A. B. M. Rabie, U. Hagg and Ruian Xu
Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
653-671
Author(s):
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
689-702
Author(s):
P. Michl and T. M. Gress
The Problem of Amino Acid Complementarity and Antisense Peptides
Journal:
Current Protein & Peptide Science
Volume:
5
Page:
507-527
Author(s):
Ignacy Z. Siemion, Marek Cebrat and Alicja Kluczyk